Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sunshine Biopharma (SBFM) FCF Margin: 2012-2024

Historic FCF Margin for Sunshine Biopharma (SBFM) over the last 11 years, with Dec 2024 value amounting to -40.68%.

  • Sunshine Biopharma's FCF Margin rose 1440.00% to -7.81% in Q3 2025 from the same period last year, while for Sep 2025 it was -19.84%, marking a year-over-year increase of 1955.00%. This contributed to the annual value of -40.68% for FY2024, which is 392.00% down from last year.
  • As of FY2024, Sunshine Biopharma's FCF Margin stood at -40.68%, which was down 10.66% from -36.76% recorded in FY2023.
  • Sunshine Biopharma's FCF Margin's 5-year high stood at -36.76% during FY2023, with a 5-year trough of -922.13% in FY2020.
  • Over the past 3 years, Sunshine Biopharma's median FCF Margin value was -40.68% (recorded in 2024), while the average stood at -67.56%.
  • In the last 5 years, Sunshine Biopharma's FCF Margin soared by 142,936bps in 2020 and then tumbled by 392bps in 2024.
  • Yearly analysis of 5 years shows Sunshine Biopharma's FCF Margin stood at -922.13% in 2020, then soared by 12,137bps to -800.75% in 2021, then spiked by 67,552bps to -125.24% in 2022, then surged by 8,847bps to -36.76% in 2023, then tumbled by 392bps to -40.68% in 2024.